Advertisement
Screener

Shattuck Labs, Inc. (STTK) Graph

2.8 / 5 stars · 68/120 Roast Me

STTK Revenue Flow

STTK Graph summary

Shattuck Labs, Inc. (STTK). Quarter ended 2026-06-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How Shattuck Labs, Inc. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.00B $0.02B$-0.02B$0.01B$0.00B$-0.02B$0.00B$-0.02B Revenue from contracts with customers, excluding assessed tax$0.00BDeclared revenue$0.00B Operating expenses$0.02BOperating income$-0.02BResearch and development$0.01BGeneral and administrative$0.00BOther income, net$0.00BNet income$-0.02B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neurogene Inc. (NGNE)$0.625B-4.46
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Advertisement